TrialBone marrow transplantation2010

Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study.

M Musso et al.PubMed ↗Publisher ↗

No numbers read from the abstract.